81 related articles for article (PubMed ID: 3468486)
1. Radioimmunotherapy of xenografts of human pancreatic carcinomas--intravenous and intratumoral application of 131I-labelled monoclonal antibodies.
Klapdor R; Lander S; Bahlo M; Montz R
Nuklearmedizin; 1986 Dec; 25(6):235-8. PubMed ID: 3468486
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
3. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125].
Klapdor R; Montz R; Greten H; Chatal JF; Douillard JY; Saccavini JC; Dietel M
Nuklearmedizin; 1985 Dec; 24(5-6):227-31. PubMed ID: 3867855
[TBL] [Abstract][Full Text] [Related]
4. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
5. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
6. Systemic radiotherapy with monoclonal antibodies. An experimental study with human neuroblastoma xenografts in nude mice.
Sautter-Bihl ML; Matzku S; Bihl H
Strahlenther Onkol; 1993 Jul; 169(7):431-7. PubMed ID: 8342117
[TBL] [Abstract][Full Text] [Related]
7. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas.
Peterson JA; Blank EW; Ceriani RL
Cancer Res; 1997 Mar; 57(6):1103-8. PubMed ID: 9067279
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
11. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of radioimmunotherapy for xenograft of human esophageal carcinoma].
Jiang P; Liu K; Chen M
Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):543-4, 575. PubMed ID: 8556546
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
Cardillo TM; Ying Z; Gold DV
Clin Cancer Res; 2001 Oct; 7(10):3186-92. PubMed ID: 11595713
[TBL] [Abstract][Full Text] [Related]
15. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
16. Influence of radiolabel on the in vivo processing of intact and fragmented anti-tumour monoclonal antibody.
Smith A; Alberto R; Shubiger PA
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):54-8. PubMed ID: 7632768
[TBL] [Abstract][Full Text] [Related]
17. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
Sautter-Bihl ML; Wessely R; Bihl H
Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
[TBL] [Abstract][Full Text] [Related]
18. Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer.
Alisauskus R; Wong GY; Gold DV
Cancer Res; 1995 Dec; 55(23 Suppl):5743s-5748s. PubMed ID: 7493339
[TBL] [Abstract][Full Text] [Related]
19. Tumor immunotherapy in the mouse with the use of 131I-labeled monoclonal antibodies.
Zalcberg JR; Thompson CH; Lichtenstein M; McKenzie IF
J Natl Cancer Inst; 1984 Mar; 72(3):697-704. PubMed ID: 6583453
[TBL] [Abstract][Full Text] [Related]
20. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
